D:zolmitriptan nasal spray: Clinical Trials

1 trial of D:zolmitriptan nasal spray, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow D:zolmitriptan nasal spray: new trials by email Literature Review of D:zolmitriptan nasal spray trials Research Report on D:zolmitriptan nasal spray

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers
A: M207 3.8mg, 30 min, upper arm, B: M207 3.8 mg, 30 min, thigh, C: M207 3.8 mg, 1 hr, upper arm - Migraine
Phase 1CompletedZosano Pharma Corporation242018-11-012020-01-18

Conditions studied

Migraine Disorders (1)

Sponsors

Zosano Pharma Corporation (1)

Countries

United States (1)

Top investigators

Don Kellerman, Pharm.D. (1)